EPTIS
BAM Logo

Fertility, gravidity

[Fertilitás, graviditás]

EPTIS Ringversuch Nr. 1276382 | Letze Änderung 2024-10-09 | URL: https://www.eptis.bam.de/pts1276382 https://www.eptis.bam.de/pts1276382

Name des Anbieters
Name des Anbieters QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Ansässig in Hungary
Sprache(n) English, Hungarian
Anmerkungen
Klassifizierung
Produktgruppen Health care / medical devices
Human test material
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
2 samples of 2 mL lyophilized serum each Alpha-1-fetoprotein (AFP) Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
AMH (Anti-Müllerian hormone) Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
HCG (total) Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
PAPP-A Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
Free beta-chain hCG Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
2 samples of 1 mL lyophilized serum each Estriol (free) Chemiluminescence immunoassay (CLIA)
Chemiluminescence magnetic microcorpuscle immunoassay (CLMIA)
Electrochemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Enzyme immunoassay: homogeneous methods (EMIT)
Fluorescent polarisation immunoassay (FPIA)
Fluorescence immunoassay (FIA), delayed-action and enhanced fluorescence immunoassay (DELFIA)
Homogen fluorescens immunoassay
Immunoradiometric assay (IRMA)
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
Luminescence (LIA), enhanced chemiluminescence immunoassay (ECI)
Multilayer film (MF-FIA)
Radioimmunoassay (RIA)
Ringversuchsziele
Zielgruppe des Ringversuchs In vitro medical laboratories
Relevante Rechtsvorschriften oder Normen CLSI GP44-A4 – Procedures for Handling and Processing of Blood Specimens for Common Laboratory Tests ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances
Weitere Ziele validation of testing methods
Teilnehmerzahl
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch
Kosten
Teilnahmegebühr on demand
Regelmässig durchgeführt Ja (four times a year)
Der Ringversuch wird durchgeführt seit
Kontaktdaten des Anbieters
Anbieter Kontaktperson
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7
6720 Szeged
Hungary

Telefon: +36 30 462 5864
Fax:
Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html
Ms. Eszter Mezey
Telefon: +36 30 462 5864
Fax:
E-Mail: mail@qualicont.com mail@qualicont.com
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Hungary, Ms Eszter Mezey. Ms Eszter Mezey.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5